Patents by Inventor Fanny Mann

Fanny Mann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antagonists of Sema3E/PlexinD1 interaction as anti-cancer agents
    Publication number: 20130149306
    Abstract: The present invention is related to the treatment of certain cancers using antagonists of the binding between a Plexin and a Sema3E. The invention may be helpful in treating primary cancer cell development and metastasis development wherein Sema3E is expressed, in particular overexpressed by the tumoral cells or the stroma. Breast cancer, in particular with distant metastases is concerned. Prostate cancer, melanoma and glioblastoma are also concerned. The antagonist may be any molecule that specifically binds to PlexinD1 or Sema3E and blocks the Sema3E/PlexinD1 binding. In an embodiment, the antagonist is a polypeptide or an antibody.
    Type: Application
    Filed: May 6, 2011
    Publication date: June 13, 2013
    Applicants: NETRIS PHARMA, CENTRE NATIONAL DE LA DECHERCHE SCIENTIFIQUE (C.N.R.S.), UNIVERSITE DE LA MEDITERRANEE AIX-MARSEILLE II
    Inventors: Amélie Royet, Fanny Mann, Sophie Chauvet, Jonathan Luchino